KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Treasury Shares: 2023

  • Arbutus Biopharma's Treasury Shares was N/A to $1.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2023, which is N/A change from last year.
  • Arbutus Biopharma's Treasury Shares amounted to $1.2 million in Q4 2023.
  • Arbutus Biopharma's Treasury Shares' 5-year high stood at $1.2 million during Q4 2023, with a 5-year trough of $1.2 million in Q4 2023.
  • Moreover, its 1-year median value for Treasury Shares was $1.2 million (2023), whereas its average is $1.2 million.